Aion Therapeutic Stock Price Prediction
| ANTCF Stock | USD 0.01 0 84.21% |
Oversold Vs Overbought
56
Oversold | Overbought |
Using Aion Therapeutic hype-based prediction, you can estimate the value of Aion Therapeutic from the perspective of Aion Therapeutic response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Aion Therapeutic to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Aion because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Aion Therapeutic after-hype prediction price | USD 0.01 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Aion |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Aion Therapeutic's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Aion Therapeutic After-Hype Price Prediction Density Analysis
As far as predicting the price of Aion Therapeutic at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Aion Therapeutic or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Aion Therapeutic, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Aion Therapeutic Estimiated After-Hype Price Volatility
In the context of predicting Aion Therapeutic's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Aion Therapeutic's historical news coverage. Aion Therapeutic's after-hype downside and upside margins for the prediction period are 0.00 and 50.54, respectively. We have considered Aion Therapeutic's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Aion Therapeutic is out of control at this time. Analysis and calculation of next after-hype price of Aion Therapeutic is based on 3 months time horizon.
Aion Therapeutic Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Aion Therapeutic is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Aion Therapeutic backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Aion Therapeutic, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
9.39 | 59.00 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.01 | 0.01 | 4.76 |
|
Aion Therapeutic Hype Timeline
Aion Therapeutic is presently traded for 0.01. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Aion is forecasted to decline in value after the next headline, with the price expected to drop to 0.01. The average volatility of media hype impact on the company price is insignificant. The price reduction on the next news is expected to be -4.76%, whereas the daily expected return is presently at 9.39%. The volatility of related hype on Aion Therapeutic is about 0.0%, with the expected price after the next announcement by competition of 0.01. About 18.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.04. Aion Therapeutic had not issued any dividends in recent years. Assuming the 90 days horizon the next forecasted press release will be in 5 to 10 days. Check out Aion Therapeutic Basic Forecasting Models to cross-verify your projections.Aion Therapeutic Related Hype Analysis
Having access to credible news sources related to Aion Therapeutic's direct competition is more important than ever and may enhance your ability to predict Aion Therapeutic's future price movements. Getting to know how Aion Therapeutic's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Aion Therapeutic may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| AXRX | Amexdrug | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| APNHF | Aspen Pharmacare Holdings | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ATHJF | Antisense Therapeutics Limited | 0.00 | 0 per month | 0.00 | 0.11 | 0.00 | 0.00 | 330.62 | |
| ABTI | Alterola Biotech | 0.00 | 0 per month | 11.66 | 0.02 | 14.75 | (19.00) | 167.22 | |
| HLTRF | HLS Therapeutics | 0.00 | 0 per month | 2.57 | 0.01 | 5.41 | (4.20) | 23.98 | |
| CPHRF | Cipher Pharmaceuticals | 0.00 | 0 per month | 7.12 | 0.04 | 4.07 | (3.57) | 133.83 | |
| LOVFF | Cannara Biotech | 0.00 | 0 per month | 0.00 | (0.06) | 7.41 | (6.90) | 36.67 | |
| KHTRF | Knight Therapeutics | 0.00 | 0 per month | 0.00 | (0.16) | 2.44 | (2.15) | 14.70 | |
| BCBCF | The BC Bud | 0.00 | 0 per month | 0.00 | 0.14 | 10.89 | (13.07) | 425.33 | |
| ACNNF | AusCann Group Holdings | 0.00 | 0 per month | 17.22 | 0.07 | 50.00 | (33.33) | 153.33 |
Aion Therapeutic Additional Predictive Modules
Most predictive techniques to examine Aion price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Aion using various technical indicators. When you analyze Aion charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Aion Therapeutic Predictive Indicators
The successful prediction of Aion Therapeutic stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Aion Therapeutic, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Aion Therapeutic based on analysis of Aion Therapeutic hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Aion Therapeutic's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Aion Therapeutic's related companies.
Story Coverage note for Aion Therapeutic
The number of cover stories for Aion Therapeutic depends on current market conditions and Aion Therapeutic's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Aion Therapeutic is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Aion Therapeutic's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Aion Therapeutic Short Properties
Aion Therapeutic's future price predictability will typically decrease when Aion Therapeutic's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Aion Therapeutic often depends not only on the future outlook of the potential Aion Therapeutic's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Aion Therapeutic's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 141.8 M | |
| Short Long Term Debt | 744.1 K | |
| Shares Float | 122.2 M |
Complementary Tools for Aion Pink Sheet analysis
When running Aion Therapeutic's price analysis, check to measure Aion Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aion Therapeutic is operating at the current time. Most of Aion Therapeutic's value examination focuses on studying past and present price action to predict the probability of Aion Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aion Therapeutic's price. Additionally, you may evaluate how the addition of Aion Therapeutic to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |